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Postoperative Application of Anti-infective Agents in 30 Patients Undergoing Stem Cell Transplantation in
Our Hospital from 2003 to 2008
OUYANG Hua（Zhongshan Hospital of Xiamen University，Xiamen 361004，China）
CHEN Jin-hui（Dept. of Pharmacy，Xiamen University，Xiamen 361001，China）
ABSTRACT OBJECTIVE：To analyze the postoperative application of anti-infective agents in patients undergoing stem cell trans-
plantation. METHODS：The application of anti-infective agents in 30 patients undergoing stem cell transplantation in the pretreat-
ment period and after operation in our hospital from 2003 to 2008 were analyzed in respect of etiology inspection，the cost of an-
ti-infective agents，utilization frequency（cases/times），duration of medication，DDDs，DUI，drug combination and its rationality.
RESULTS：The infection was found in 26 cases after operation，accounting for 86.67％. Pathogens were found out in 11 cases. The
total cost of anti-infective agents was 327 598.23 yuan. The DUI of 7 kinds of top 10 anti-infective agents in terms of DDDs were
less than 1 and that of other 3 were more than 1. In terms of drug combination，two-drug consisted of 73.08％（38 cases/times），
three-drug 25.00％（13 cases/times）and four-drug 1.92％（1 cases/times）. CONCLUSION：The postoperative application of an-
ti-infective agents in patients undergoing stem cell transplantation in our hospital is rational on the whole.
KEY WORDS Stem cell transplantation；Anti-infective agents；DDDs；Analysis
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联用药 38例/次，占 73.08％；三联用药 13例/次，占 25.00％；四
联用药1例/次，占1.92％。联用情况统计详见表4。
表3 应用例/次排序列前10位的药品统计
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Analysis on Safety of Drug Use in 291 Surgical Patients of Our Hospital in 2009
ZHENG Jia-hao（Leqing Municipal Hospital of TCM of Zhejiang Province，Leqing 325600，China）
ABSTRACT OBJECTIVE：To probe into the situation and safety of drug use in surgical patients of our hospital and new prob-
lems resulted from ppatients controlled analgesia（PCA）. METHODS：Medication and the safety of drug used for PCA in 291 surgi-
cal patients of orthopedic department and general surgery department of our hospital in 2009 were analyzed. RESULTS：90 catego-
ries of drugs were involved and utilization frequency was 2 627 with each person of 9.03. 70.45％ of patients received PCA after op-
eration. There were statistical significance in difference of applying anesthetic agents，analgesics and other drugs in different depart-
ments（P＜0.01）. CONCLUSION：Application of PCA in surgical operation increases the potential of insecurity. Safety monitoring
of drug use in surgical patients should be strengthened to improve rationality of drug use.













性 194例，女性 97例；年龄 8～88岁，平均（45.40±18.20）岁。
其中，8～17岁10例，18～59岁181例，60～69岁41例，70～88
岁59例。
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